ORIGINAL ARTICLE
Open Access
Rapid Uptake of the Subcutaneous Injectable in Burkina Faso: Evidence From PMA2020 Cross-Sectional Surveys
Georges Guiella, Shani Turke, Hamadou Coulibaly, Scott Radloff and Yoonjoung Choi
Global Health: Science and Practice March 2018, 6(1):73-81; https://doi.org/10.9745/GHSP-D-17-00260
Georges Guiella
aInstitut Supérieur des Sciences de la Population (ISSP), Université Ouaga 1 Pr Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.
Shani Turke
bBill & Melinda Gates Institute for Population and Reproductive Health, Department of Population, Family, and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Hamadou Coulibaly
bBill & Melinda Gates Institute for Population and Reproductive Health, Department of Population, Family, and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Scott Radloff
bBill & Melinda Gates Institute for Population and Reproductive Health, Department of Population, Family, and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Yoonjoung Choi
bBill & Melinda Gates Institute for Population and Reproductive Health, Department of Population, Family, and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Submit a Comment to This Article
Jump to comment:
No comments have been published for this article.
In this issue
Global Health: Science and Practice
Vol. 6, No. 1
March 21, 2018
Rapid Uptake of the Subcutaneous Injectable in Burkina Faso: Evidence From PMA2020 Cross-Sectional Surveys
Georges Guiella, Shani Turke, Hamadou Coulibaly, Scott Radloff, Yoonjoung Choi
Global Health: Science and Practice Mar 2018, 6 (1) 73-81; DOI: 10.9745/GHSP-D-17-00260